Ontology highlight
ABSTRACT:
SUBMITTER: Pol J
PROVIDER: S-EPMC4801444 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature
Pol Jonathan J Buqué Aitziber A Aranda Fernando F Bloy Norma N Cremer Isabelle I Eggermont Alexander A Erbs Philippe P Fucikova Jitka J Galon Jérôme J Limacher Jean-Marc JM Preville Xavier X Sautès-Fridman Catherine C Spisek Radek R Zitvogel Laurence L Kroemer Guido G Galluzzi Lorenzo L
Oncoimmunology 20151208 2
Oncolytic virotherapy relies on the administration of non-pathogenic viral strains that selectively infect and kill malignant cells while favoring the elicitation of a therapeutically relevant tumor-targeting immune response. During the past few years, great efforts have been dedicated to the development of oncolytic viruses with improved specificity and potency. Such an intense wave of investigation has culminated this year in the regulatory approval by the US Food and Drug Administration (FDA) ...[more]